Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 33,598	$ 13,789
Marketable securities	18,944	19,537
Trade accounts receivable, net	5,427	6,368
Loan receivable from related party	0	2,001
Other current assets	6,172	2,316
Total current assets	64,141	44,011
Marketable securities	0	8,292
Property and equipment, net	2,390	2,875
Intangibles, net	33,170	6,611
Goodwill	8,229	1,114
Lease right of use assets	4,720	1,300
Other assets	1,127	673
Total assets	113,777	64,876
Current liabilities:
Accounts payable and other accrued liabilities	5,989	4,727
Deferred revenue, current	4,145	2,989
Total current liabilities	10,134	7,716
Lease liabilities, long-term	5,977	1,028
Other long-term liabilities	76	752
Total liabilities	16,187	9,496
Commitments and contingencies (Note 17)
Shareholders’ equity:
Preferred stock (par value $0.001 per share, 2,500 authorized, 10 shares issued and outstanding at December 31, 2022 and December 31, 2021)	50	50
Common stock (par value $0.001 per share, 50,000 authorized, 20,260 and 16,940 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively)	20	17
Additional paid-in capital	367,692	261,324
Accumulated deficit	(265,809)	(206,011)
Accumulated other comprehensive loss	(4,363)	0
Total shareholders’ equity	97,590	55,380
Total liabilities and shareholders’ equity	$ 113,777	$ 64,876